My research aims to define the dynamics of endogenous RNA modifications during immunoinflammatory processes that will help us to better understand the physiological immune responses. My long-term goal is to provide novel prognostic/diagnostic and therapeutic platforms for immune-mediated inflammatory diseases (IMID), marked by derailed immunoinflammatory processes, such as autoimmune disorders, cardiovascular disease (e.g atherosclerosis), cancer, and other relevant pathological conditions.

Linkedin: https://www.linkedin.com/in/aikaterini-gatsiou-phd-ba677858/

Google Scholar: https://scholar.google.gr/citations?hl=de&user=teDmup0AAAAJ

Twitter: https://twitter.com/Aik_Gatsiou

• Mareti A, Kritsioti C, Georgiopoulos G, Vlachogiannis NI, Delialis D, Sachse M, Sopova K, Koutsoukis A, Kontogiannis C, Patras R, Tual-Chalot S, Koureas A, Gatsiou A, Stellos K, Stamatelopoulos K. Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease. European Journal of Preventive Cardiology 2019, Epub ahead of print.
• Stellos K, Gatsiou A, Stamatelopoulos K, Perisic Matic L, John D, Lunella FF, Jae N, Rossbach O, Amrhein C, Sigala F, Boon RA, Furtig B, Manavski Y, You X, Uchida S, Keller T, Boeckel J-N, Franco-Cereceda A, Maegdefessel L, Chen W, Schwalbe H, Bindereif A, Eriksson P, Hedin U, Zeiher AM, Dimmeler S. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nature Medicine 2016, 22(10), 1140-1150.
• Gatsiou A, Stellos K. Dawn of Epitranscriptomic Medicine. Circulation: Genomic and Precision Medicine 2018, 11(9), e001927.
• Vlachogiannis NI, Gatsiou A, Silvestris DA, Stamatelopoulos K, Tektonidou MG, Gallo A, Sfikakis PP, Stellos K. Increased adenosine-to-inosine RNA editing in rheumatoid arthritis. Journal of Autoimmunity 2019, epub ahead of print.
• Stamatelopoulos K, Georgiopoulos G, Athanasouli F, Nikolaou P-E, Lykka M, Roussou M, Gavriatopoulou M, Laina A, Trakada G, Charakida M, Delialis D, Petropoulos I, Pamboukas C, Manios E, Karakitsou M, Papamichael C, Gatsiou A, Lambrinoudaki I, Terpos E, Stellos K, Andreadou I, Dimopoulos MA, Kastritis E. Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis. Circulation Research 2019, 125(8), 744-758.
• Stamatelopoulos K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, Boeddinghaus J, Sopova K, Gatsiou A, Amrhein C, Biener M, Vafaie M, Athanasouli F, Stakos D, Pateras K, Twerenbold R, Badertscher P, Nestelberger T, Dimmeler S, Katus HA, Zeiher AM, Mueller C, Giannitsis E, Stellos K. Amyloid-ß (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study. Annals of Internal Medicine 2018, 168(12), 855-865.
• Laina A, Gatsiou A, Georgiopoulos G, Stamatelopoulos K, Stellos K. RNA therapeutics in cardiovascular precision medicine. Frontiers in Physiology 2018, 9, 953.
• Stamatelopoulos K, Sibbing D, Rallidis LS, Georgiopoulos G, Stakos D, Braun S, Gatsiou A, Sopova K, Kotakos C, Varounis C, Tellis CC, Kastritis E, Alevizaki M, Tselepis AD, Alexopoulos P, Laske C, Keller T, Kastrati A, Dimmeler S, Zeiher AM, Stellos K. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease. Journal of the American College of Cardiology 2015, 65(9), 904-916.